Details of the Drug
General Information of Drug (ID: DM6WJ4K)
| Drug Name |
4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
4-HYDROXY-1,2,5-OXADIAZOLE-3-CARBOXYLIC ACID; 4-Hydroxy-furazan-3-carboxylic acid; 66313-36-8; OXQ; AC1L9M6V; 1,2,5-oxadiazole, OXD1; SCHEMBL1043406; CTK8F6043; CTK7J1234; BDBM23232; MolPort-002-679-216; ZINC6523895; FCH841687; AKOS030214651; AKOS000301440; DB02401; MCULE-2928095407; ST077901; TR-055247; AX8302019; 4-oxo-1,2,5-oxadiazole-3-carboxylic acid; BB 0257536
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 130.06 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 0.3 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 5 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


